Cognition Therapeutics
CGTX
CGTX
36 hedge funds and large institutions have $10.4M invested in Cognition Therapeutics in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
Holders
36
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$64.8K | |
| 2 | +$58K | |
| 3 | +$29.5K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$26.6K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$9.13K |
Top Sellers
| 1 | -$3.15K | |
| 2 | -$2.45K | |
| 3 | -$1.12K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.01K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$730 |